| 期刊論文| 1. | Chao, T. F.、Lip, G. Y.、Liu, C. J.、Tuan, T. C.、Chen, S. J.、Wang, K. L.、Lin, Y. J.、Chang, S. L.、Lo, L. W.、Hu, Y. F.、Chen, T. J.、Chiang, C. E.、Chen, S. A.(2016)。Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study。Stroke，47(10)，2462-2469。   | | 2. | Aguilar, M. I.、Hart, R.(2005)。Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks。Cochrane Database Syst Rev，3，CD001927。 | | 3. | López-López, J. A.、Sterne, J. A. C.、Thom, H. H. Z.、Higgins, J. P. T.、Hingorani, A. D.、Okoli, G. N.、Davies, P. A.、Bodalia, P. N.、Bryden, P. A.、Welton, N. J.、Hollingworth, W.、Caldwell, D. M.(2017)。Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis。BMJ，359，j5058。 | | 4. | Ruff, C. T.、Giugliano, R. P.、Braunwald, E.、Hoffinan, E. B.、Deenadayalu, N.、Ezekowitz, M. D.、Camm, A. J.、Weitz, J. I.、Lewis, B. S.、Parkhomenko, A.、Yamashita, T.、Antman, E. M.(2014)。Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials。Lancet，383(9921)，955-962。 | |